Minimally invasive versus open esophagectomy after neoadjuvant therapy for esophageal cancer: a meta-analysis

por Jin, Zixian, Zhu, Kanghao, Sun, Jiajing, Zhang, Jian, Zhang, Bo
Publicado 2023

The role of miR-145-5p in esophageal squamous cell carcinoma tumor-associated macrophages and selection of immunochemotherapy

por Lin, Junhong, Wu, Sikai, Zhu, Kanghao, Zhang, Jian, Shi, Xiaoshun, Shen, Jianfei, Xu, Jianfeng
Publicado 2022

Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis

por Xu, Congcong, Zhu, Kanghao, Chen, Dong, Ruan, Yuhang, Jin, Zixian, Qiu, Hongbin, Chen, Baofu, Shen, Jianfei
Publicado 2021

Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in the second-line treatment of advanced esophageal squamous cell carcinoma: a meta-analysis and systematic...

por Zhu, Kanghao, Chen, Hui, Xu, Congcong, Chen, Dong, Jin, Zixian, Ren, Sijia, Witharana, Pasan, Chen, Baofu, Shen, Jianfei
Publicado 2023

Efficacy and Safety of Neoadjuvant Targeted Therapy vs. Neoadjuvant Chemotherapy for Stage IIIA EGFR-Mutant Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis

por Chen, Dong, Jin, Zixian, Zhang, Jian, Xu, Congcong, Zhu, Kanghao, Ruan, Yuhang, Zhang, Bo, Chen, Baofu, Shen, Jianfei
Publicado 2021

A single-arm, multicenter, phase II clinical study of tislelizumab plus albumin-bound paclitaxel/cisplatin as neoadjuvant therapy for borderline resectable esophageal squamous cell...

por Li, Xiaodong, Xu, Congcong, Qiu, Hongbin, Chen, Dong, Zhu, Kanghao, Zhang, Bo, Zhang, Jian, Xu, Anyi, Wang, Chunguo, Shen, Jianfei
Publicado 2022